UK regulator approves first daily GLP-1 weight loss pill
The Medicines and Healthcare products Regulatory Agency has approved a daily semaglutide tablet for adults living with obesity or weight-related health conditions. While the treatment is currently limited to private prescriptions, it offers a new option for those seeking clinical support alongside diet and exercise to manage their weight.
Source: Bristol Post
National
Read the full story